HUYABIO is the leader in accelerating the global development of novel biopharmaceutical product opportunities originating in China enabling faster, more cost-effective and lower-risk drug development in the global markets. Through extensive collaboration with biopharmaceutical, academic and commercial organizations, it has built the largest China-sourced compound portfolio covering all therapeutic areas. With offices in the US, Japan, South Korea, Canada, Ireland and eight strategic locations across China, the Company has become a partner of choice to accelerate product development and maximize value globally.

Therapeutics

Pharmaceutical

Biotechnology

HUYABIO International

Christopher Kemmerer

Holly Jing

Francesco Santo

Hao L.

Rick Witte

Farbod Shojaei

Nicola Dowling

Ivan O'Toole

Jason Wang

Hiroshi Onogi

Zhijun Wang

Jerome Riebman

William Davis

Suzanne J. Romano

Gloria Lee

Clement Gingras

Alan Kholos

The Executive Operations team at HUYABIO International oversees strategic decision-making, operational efficiency, and corporate governance to ensure the successful global development of biopharmaceutical products. This team coordinates high-level functions across finance, commercial operations, product evaluation, and development, providing leadership and direction to align with the company's mission to accelerate and maximize the value of novel biopharmaceutical opportunities from China.

Executive Operations

Leadership Team

Business Development & Operations

Executive Operations

About

Team members

Other teams at HUYABIO International

Leadership Team

Business Development & Operations